François Labarthe

645 total citations
28 papers, 412 citations indexed

About

François Labarthe is a scholar working on Physiology, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, François Labarthe has authored 28 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 10 papers in Clinical Biochemistry and 7 papers in Molecular Biology. Recurrent topics in François Labarthe's work include Lysosomal Storage Disorders Research (11 papers), Metabolism and Genetic Disorders (10 papers) and Mitochondrial Function and Pathology (7 papers). François Labarthe is often cited by papers focused on Lysosomal Storage Disorders Research (11 papers), Metabolism and Genetic Disorders (10 papers) and Mitochondrial Function and Pathology (7 papers). François Labarthe collaborates with scholars based in France, Canada and United States. François Labarthe's co-authors include Bertrand Bouchard, Basil J. Petrof, Christine Des Rosiers, Gawiyou Danialou, Maya Khairallah, Priya S. Kishnani, Claude Jardel, A. De Muret, Frédèric Gottrand and Jan‐Willem Taanman and has published in prestigious journals such as PLoS ONE, Journal of Hepatology and The Journal of Pediatrics.

In The Last Decade

François Labarthe

24 papers receiving 409 citations

Peers

François Labarthe
İlyas Okur Türkiye
Ayesha Ahmad United States
Go Tajima Japan
J Calvin United Kingdom
Jun Ye China
John Fernandes Netherlands
Mark Sharrard United Kingdom
İlyas Okur Türkiye
François Labarthe
Citations per year, relative to François Labarthe François Labarthe (= 1×) peers İlyas Okur

Countries citing papers authored by François Labarthe

Since Specialization
Citations

This map shows the geographic impact of François Labarthe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Labarthe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Labarthe more than expected).

Fields of papers citing papers by François Labarthe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Labarthe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Labarthe. The network helps show where François Labarthe may publish in the future.

Co-authorship network of co-authors of François Labarthe

This figure shows the co-authorship network connecting the top 25 collaborators of François Labarthe. A scholar is included among the top collaborators of François Labarthe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Labarthe. François Labarthe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Labarthe, François, Caroline Moreau, Jean‐Baptiste Arnoux, et al.. (2023). Newborn Screening of Primary Carnitine Deficiency: An Overview of Worldwide Practices and Pitfalls to Define an Algorithm before Expansion of Newborn Screening in France. International Journal of Neonatal Screening. 9(1). 6–6. 9 indexed citations
3.
Arnoux, Armelle, Anaïs Brassier, Samia Pichard, et al.. (2022). Transition from child to adult health care for patients with lysosomal storage diseases in France: current status and priorities—the TENALYS study, a patient perspective survey. Orphanet Journal of Rare Diseases. 17(1). 68–68. 8 indexed citations
4.
Kishnani, Priya S., David Kronn, Anaïs Brassier, et al.. (2022). Safety and efficacy of avalglucosidase alfa in individuals with infantile-onset Pompe disease enrolled in the phase 2, open-label Mini-COMET study: The 6-month primary analysis report. Genetics in Medicine. 25(2). 100328–100328. 28 indexed citations
5.
Huidekoper, Hidde H., Michelle E. Kruijshaar, Dimitris Rizopoulos, et al.. (2022). Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease: A multicentre observational follow-up study of the European Pompe Consortium. Molecular Genetics and Metabolism. 135(2). S39–S39. 1 indexed citations
6.
Chabrol, B., Pierre Broué, D. Dobbelaere, et al.. (2018). Transition from pediatric to adult care in adolescents with hereditary metabolic diseases: Specific guidelines from the French network for rare inherited metabolic diseases (G2M). Archives de Pédiatrie. 25(5). 344–349. 15 indexed citations
7.
Lefort, Bruno, Cécile Acquaviva, M. Tardieu, et al.. (2017). Pharmacological inhibition of carnitine palmitoyltransferase 1 restores mitochondrial oxidative phosphorylation in human trifunctional protein deficient fibroblasts. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(6). 1292–1299. 11 indexed citations
8.
Labarthe, François, M. Tardieu, & David Cheillan. (2015). Maladies métaboliques: quels dépistages?. Archives de Pédiatrie. 22(5). 77–78.
9.
Favrais, Géraldine, M. Tardieu, Thierry Perez, et al.. (2015). Intracranial Pressure Monitoring Demonstrates that Cerebral Edema Is Not Correlated to Hyperammonemia in a Child with Ornithine Transcarbamylase Deficiency. JIMD Reports. 27. 55–62. 1 indexed citations
10.
11.
Banugaria, Suhrad G., Sean N. Prater, Trusha Patel, et al.. (2013). Approach to management of cross-reactive immunologic material (CRIM)-negative infantile pompe patients treated with ERT: Role of immune modulation in changing the natural history. Molecular Genetics and Metabolism. 108(2). S23–S23. 1 indexed citations
12.
Feillet, François, David Cheillan, François Labarthe, et al.. (2012). Déficit en acyl-CoA-déshydrogénase des acides gras à chaîne moyenne (MCAD) : consensus français pour le dépistage, le diagnostic, et la prise en charge. Archives de Pédiatrie. 19(2). 184–193. 18 indexed citations
13.
Lauzier, Benjamin, Fanny Vaillant, Clémence Merlen, et al.. (2012). Metabolic effects of glutamine on the heart: Anaplerosis versus the hexosamine biosynthetic pathway. Journal of Molecular and Cellular Cardiology. 55. 92–100. 52 indexed citations
14.
Labarthe, François, et al.. (2008). Néovascularisation choroïdienne au cours d’un déficit en Long-Chain 3-Hydroxyacyl CoA Dehydrogenase (LCHAD). Journal Français d Ophtalmologie. 31(10). 993–998. 3 indexed citations
15.
Maurage, C.A., et al.. (2006). L'enfant avaleur d'air: définition et prise en charge. Archives de Pédiatrie. 14(1). 10–14. 3 indexed citations
16.
Labarthe, François, Jean François Benoist, M. Brivet, et al.. (2006). Partial hypoparathyroidism associated with mitochondrial trifunctional protein deficiency. European Journal of Pediatrics. 165(6). 389–391. 14 indexed citations
17.
Khairallah, Maya, François Labarthe, Bertrand Bouchard, et al.. (2004). Profiling substrate fluxes in the isolated working mouse heart using13C-labeled substrates: focusing on the origin and fate of pyruvate and citrate carbons. American Journal of Physiology-Heart and Circulatory Physiology. 286(4). H1461–H1470. 59 indexed citations
18.
Delarue, Jacques, François Labarthe, & Richard A. Cohen. (2003). Fish-oil supplementation reduces stimulation of plasma glucose fluxes during exercise in untrained males. British Journal Of Nutrition. 90(4). 777–786. 20 indexed citations
19.
Rottembourg, Diane, et al.. (2001). Headache During Mesalamine Therapy: A Case Report of Mesalamine-Induced Pseudotumor Cerebri. Journal of Pediatric Gastroenterology and Nutrition. 33(3). 337–338. 12 indexed citations
20.
Maurage, C.A., et al.. (1997). Comment alimente-on actuellement un enfant hospitalise pour diarrhee aigue. Archives de Pédiatrie. 4. 241s–241s.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026